SEC Form 4 · accession 0001192482-17-000227
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gwen A Melincoff
Director
Period of report
Aug 9, 2017
Accepted (ET)
Aug 11, 2017 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Purchase)F1 | $9.89 | Aug 9, 2017 | A | 25,067 | A | — | Aug 9, 2027 | Common Stock | 25,067 | 25,067 | D |
Explanation of responses
- F1The option vests and becomes exercisable on August 9, 2018, subject to the director's continued service with the issuer.